Ikarian Capital, LLC Intercept Pharmaceuticals, Inc. Put Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $15,708 - $21,483	1,100 New	1,100 $18,000
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $1.39 Million - $1.9 Million	-35,500 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $6.38 Million - $12.6 Million	-136,600 Reduced 79.37%	35,500 $1.7 Million
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $28.2 Million - $69.2 Million	-582,800 Reduced 77.2%	172,100 $10.8 Million
Q4 2019 Jan 31, 2020	BUY	$57.36 - $124.1 $43.3 Million - $93.7 Million	754,900 New	754,900 $93.5 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.